Circulating proteins as potential biomarkers of sunitinib and interferon-α efficacy in treatment-naïve patients with metastatic renal cell carcinoma

PURPOSE: We investigated potential biomarkers of efficacy in a phase III trial of sunitinib versus interferon-alpha (IFN-α), first-line in metastatic renal cell carcinoma (mRCC), by analyzing plasma levels of vascular endothelial growth factor (VEGF)-A, VEGF-C, soluble VEGF receptor-3 (sVEGFR-3) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Harmon, Charles S., DePrimo, Samuel E., Figlin, Robert A., Hudes, Gary R., Hutson, Thomas E., Michaelson, M. Dror, Négrier, Sylvie, Kim, Sindy T., Huang, Xin, Williams, J. Andrew, Eisen, Tim, Motzer, Robert J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3889677/
https://www.ncbi.nlm.nih.gov/pubmed/24220935
http://dx.doi.org/10.1007/s00280-013-2333-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3889677/
https://www.ncbi.nlm.nih.gov/pubmed/24220935
http://dx.doi.org/10.1007/s00280-013-2333-4

Ejemplares similares